Proscia Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
101
- Latest Deal Type
-
Series C
- Latest Deal Amount
-
$9M
- Investors
-
21
Proscia General Information
Description
Developer of a digital pathology platform designed to enhance cancer diagnosis. The company's platform uses computing technologies that unlock hidden data not visible to the human eye and turn that data into valuable insights, enabling physicians to improve patient outcomes and accelerate the development of life-saving advances.
Contact Information
Website
www.proscia.comCorporate Office
- 1700 Market Street
- 23rd Floor
- Philadelphia, PA 19103
- United States
Corporate Office
- 1700 Market Street
- 23rd Floor
- Philadelphia, PA 19103
- United States
Proscia Timeline
Proscia Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Later Stage VC (Series C) | 11-Jan-2024 | $9M | Completed | Generating Revenue | ||
| 9. Later Stage VC (Series C) | 14-Jun-2022 | Completed | Generating Revenue | |||
| 8. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 7. Later Stage VC (Series B) | 30-Nov-2020 | Completed | Generating Revenue | |||
| 6. Debt - PPP | 10-Apr-2020 | Completed | Generating Revenue | |||
| 5. Early Stage VC (Series A) | 01-Jul-2018 | Completed | Generating Revenue | |||
| 4. Seed Round | 08-May-2017 | Completed | Generating Revenue | |||
| 3. Seed Round | 05-Jul-2016 | Completed | Generating Revenue | |||
| 2. Grant | 03-Apr-2015 | $10K | $70K | Completed | Startup | |
| 1. Capitalization | 01-Jul-2014 | $70K | $70K | Completed | Startup |
Proscia Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series B | ||||||||
| Series A | ||||||||
| Seed 1 | 882,400 | $0.001000 | $0.79 | $0.79 | 1x | $0.79 | 3.02% | |
| Seed | 1,585,500 | $0.001000 | $0.56 | $0.56 | 1x | $0.56 | 5.42% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Proscia Comparisons
Industry
Financing
Details
Proscia Competitors (30)
One of Proscia’s 30 competitors is CureMetrix, a Venture Capital-Backed company based in San Diego, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| CureMetrix | Venture Capital-Backed | San Diego, CA | ||||
| HealthMyne | Formerly VC-backed | Madison, WI | ||||
| Paige | Venture Capital-Backed | New York, NY | ||||
| InsightRx | Venture Capital-Backed | San Francisco, CA | ||||
| PathologyWatch | Formerly VC-backed | Salt Lake City, UT |
Proscia Patents
Proscia Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20230260125-A1 | Digital pathology artificial intelligence quality check | Pending | 16-Feb-2022 | ||
| AU-2023222757-A1 | Digital pathology artificial intelligence quality check | Pending | 16-Feb-2022 | ||
| EP-4479789-A1 | Digital pathology artificial intelligence quality check | Pending | 16-Feb-2022 | ||
| AU-2023216695-A1 | Systems and methods of generating medical concordance scores | Pending | 04-Feb-2022 | ||
| EP-4466715-A1 | Systems and methods of generating medical concordance scores | Pending | 04-Feb-2022 | G16H50/20 |
Proscia Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Proscia Investors (21)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Alpha Intelligence Capital | Venture Capital | Minority | ||
| Ebridge Ventures | Venture Capital | Minority | ||
| Highline Capital Management | Hedge Fund | Minority | ||
| Interwoven Ventures | Venture Capital | Minority | ||
| Triangle Peak Partners | Venture Capital | Minority |
Proscia FAQs
-
When was Proscia founded?
Proscia was founded in 2014.
-
Where is Proscia headquartered?
Proscia is headquartered in Philadelphia, PA.
-
What is the size of Proscia?
Proscia has 101 total employees.
-
What industry is Proscia in?
Proscia’s primary industry is Decision/Risk Analysis.
-
Is Proscia a private or public company?
Proscia is a Private company.
-
What is the current valuation of Proscia?
The current valuation of Proscia is .
-
What is Proscia’s current revenue?
The current revenue for Proscia is .
-
How much funding has Proscia raised over time?
Proscia has raised $79.3M.
-
Who are Proscia’s investors?
Alpha Intelligence Capital, Ebridge Ventures, Highline Capital Management, Interwoven Ventures, and Triangle Peak Partners are 5 of 21 investors who have invested in Proscia.
-
Who are Proscia’s competitors?
CureMetrix, HealthMyne, Paige, InsightRx, and PathologyWatch are some of the 30 competitors of Proscia.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
